Retrophin, Inc., Overview
Company Headquarters: San Diego, California, US
Founded: 2011
Workforce: ~214
Company Working: Retrophin, Inc., is a biopharmaceutical company that develops and delivers therapies for people with rare diseases. It operates in different therapeutic areas such as fosmetpantotenate for pantothenate kinase-associated neurodegeneration (PKAN), and other life-threatening neurological disorders. The company focuses on the identification, development, acquisition, and commercialization of therapies for the treatment of rare diseases.
Strategy
Retrophin, Inc., strategizes to develop products to treat rare diseases characterized by serving them with unmet medical needs. The company aims to become a prominent, global, and fully integrated biopharmaceutical company within the rare disease community.
